Delcath Systems

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCTH and other ETFs, options, and stocks.

About DCTH

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. 

CEO
Gerard J. Michel
CEOGerard J. Michel
Employees
76
Employees76
Headquarters
Queensbury, New York
HeadquartersQueensbury, New York
Founded
1988
Founded1988
Employees
76
Employees76

DCTH Key Statistics

Market cap
132.89M
Market cap132.89M
Price-Earnings ratio
-1.71
Price-Earnings ratio-1.71
Dividend yield
Dividend yield
Average volume
355.43K
Average volume355.43K
High today
$5.05
High today$5.05
Low today
$4.76
Low today$4.76
Open price
$5.03
Open price$5.03
Volume
219.50K
Volume219.50K
52 Week high
$7.99
52 Week high$7.99
52 Week low
$2.25
52 Week low$2.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.